To investigate the prognostic relevance of sex, age, and tumor genetics in papillary thyroid carcinoma (PTC) and how these factors interact to influence disease-specific mortality.
Approach:
Study Design: A multinational investigation analyzing the impact of sex, age, and specific genetic mutations (BRAF V600E and TERT promoter mutations) on PTC outcomes.
Key Findings:
Male sex is associated with higher PTC-specific mortality, particularly in tumors with BRAF V600E or TERTp mutations.
The interaction between male sex and age significantly influences mortality risk, especially in men aged 45 years or older with both mutations.
Sex is not an independent prognostic factor in genetically wild-type tumors.
Limitations:
The retrospective nature of the study may introduce variability in treatment practices and molecular testing across different centers.
Differences in treatment protocols among participating institutions could affect outcomes.
Standardized preprocessing, multicenter datasets, external validation, and interpretable models may matter more than further gains in classification accuracy